MS news collection · MS Living Library

Adaptive software for head-operated computer controls
IEEE Trans Neural Syst Rehabil Eng. 2004 Mar;12(1):102-11
Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging
Neuroradiology. 2004 Apr 28
Remyelinating and neuroprotective treatments in multiple sclerosis
Expert Opin Investig Drugs. 2004 Apr;13(4):331-47
Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis
Neurology. 2004 Apr 27;62(8):1432-4
17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death
J Neurochem. 2004 May;89(3):660-73
Amidines as amide bond replacements in VLA-4 antagonists
Bioorg Med Chem Lett. 2004 May 3;14(9):2323-6
Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis
Trends Pharmacol Sci. 2004 Feb;25(2):67-71
Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis
Neuroimage. 2004 May;22(1):353-9
Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions
J Neuropathol Exp Neurol. 2004 Mar;63(3):262-73
Dysregulation of costimulation in EAE and Multiple Sclerosis
Pol Merkuriusz Lek. 2003 Dec;15(90):570-3
Spectral pattern of total creatine and trimethyl ammonium in multiple sclerosis
Magn Reson Imaging. 2004 Apr;22(3):427-9
Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis
Arch Neurol. 2004 Apr;61(4):536-40
Why physicians need to look more closely at the use of complementary and alternative medicine by multiple sclerosis patients
Eur J Neurol. 2004 Apr;11(4):263-7
Clinical characteristics of multiple sclerosis in Vasterbotten County in northern Sweden
J Neurol Neurosurg Psychiatry. 2004 May;75(5):711-6
Comparing clinical and neuropsychological indices of multiple sclerosis and inflammatory demyelinating polyneuropathy
Zh Nevrol Psikhiatr Im S S Korsakova. 2004;104(3):52-4
Glatiramer acetate for the treatment of multiple sclerosis
Expert Opin Pharmacother. 2004 Apr;5(4):875-91
Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis
J Neurol Neurosurg Psychiatry. 2004 May;75(5):706-10
Retrospective assessment of frequency of dosing of sustained release opiate preparations in chronic pain patients
Pain Med. 2002 Jun;3(2):185.
Chronic barium intoxication disrupts sulphated proteoglycan synthesis: a hypothesis for the origins of multiple sclerosis
Med Hypotheses. 2004;62(5):746-54
New Study Suggests Variations In How MS Tissue Damage Occurs
April 21, 2004
American Academy of Neurology 56th Annual Meeting
May 10, 2004
AAN: Avonex (Interferon Beta-1a) Slows Disability Progression In Secondary Progressive Multiple Sclerosis
May 9, 2001
AVONEX(R) (Interferon beta-1a) Is First Drug to Show an Effect on Primary Progressive MS, One of the Most Aggressive Forms of the Disease
Monday September 11, 8:50 am Eastern Time
Genetics of multiple sclerosis
Lancet Neurol. 2004 Feb;3(2):104-10
Regulation of cellular and molecular trafficking across human brain endothelial cells by Th1- and Th2-polarized lymphocytes
J Neuropathol Exp Neurol. 2004 Mar;63(3):223-32
Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis
Arch Neurol. 2004 Apr;61(4):529-32
Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo
Brain. 2004 Apr 16
Multiple sclerosis associated with neurofibromatosis type I
Rev Neurol (Paris). 2004 Apr;160(4 Pt 1):447-51
The management of multiple sclerosis: current and future therapies
Drugs Today (Barc). 1998 Mar;34(3):267-82
Deep brain stimulation in the management of neuropathic pain and multiple sclerosis tremor
J Clin Neurophysiol. 2004 Jan-Feb;21(1):31-9
Epstein-Barr virus in pediatric multiple sclerosis
JAMA. 2004 Apr 21;291(15):1875-9
Improving the quality of life of patients with multiple sclerosis: diagnosis
Drugs Today (Barc). 1998 Feb;34(2):145-56
The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosisA monthly MRI study after triple-dose gadolinium-DTPA
J Neurol. 2004 Apr;251(4):432-9
Diagnostic use of cerebral and extracerebral oxysterols
Clin Chem Lab Med. 2004 Feb;42(2):186-91
Differential diagnosis of Lyme borreliosis
MMW Fortschr Med. 2003 Apr 10;145(15):40-2, 45
Marriage, impairment, and acceptance in persons with multiple sclerosis
West J Nurs Res. 2004 Apr;26(3):266-85; discussion 286-92
Evaluation of the Modified Jebsen Test of Hand Function and the University of Maryland Arm Questionnaire for Stroke
Clin Rehabil. 2004 Mar;18(2):195-202
DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain
J Neurol. 2004 Apr;251(4):440-4
Profiles of gene expression in human autoimmune disease
Cell Biochem Biophys. 2004;40(2):81-96
Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease
J Clin Invest. 2004 Apr;113(7):990-7
Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis
Acta Neurol Scand. 2004 May;109(5):342-7
The beneficial and detrimental effects of linoleic acid on autoimmune disorders
Autoimmunity. 2004 Feb;37(1):73-5
Estrogen influences the differentiation, maturation and function of dendritic cells in rats with experimental autoimmune encephalomyelitis
Acta Pharmacol Sin. 2004 Apr;25(4):508-13
Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients
Clin Immunol. 2004 Apr;111(1):38-46
Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity
J Med Chem. 2004 Apr 22;47(9):2326-36
Probable epitopes: relationships between myelin basic protein antigenic determinants and viral and bacterial proteins
Neuroinformatics. 2004;2(1):59-70
Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis
J Neurol. 2004 Apr;251(4):407-13
Methotrexate for multiple sclerosis
Cochrane Database Syst Rev. 2004;2:CD003208
A comparison of the benefits of mitoxantrone and other recent therapeutic approaches in multiple sclerosis
Expert Opin Pharmacother. 2004 Apr;5(4):747-65
Cerebrospinal fluid insulin-like growth factor-1, insulin growth factor binding protein-2 or nitric oxide are not increased in MS or ALS
Acta Neurol Scand. 2004 May;109(5):337-41
Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren syndrome
Scand J Rheumatol. 2003;32(6):337-42
Paroxysmal phenomena in multiple sclerosis
Neurol Neurochir Pol. 2003;37 Suppl 5:127-31
Use of a visual analogue scale in a daily patient diary: modelling cross-sectional time-series data on health-related quality of life
Soc Sci Med. 2004 Jul;59(2):351-60
Pirfenidone
IDrugs. 2004 Feb;7(2):166-72
Posterior fossa lesion volume and slowed information processing in multiple sclerosis
Brain. 2004 Apr 16
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
J Exp Med. 2004 Apr 5;199(7):971-9
The neuropsychiatry of multiple sclerosis
Can J Psychiatry. 2004 Mar;49(3):157-63
Thyroid autoimmunity and dysfunction associated with type I interferon therapy
Clin Exp Med. 2004 Apr;3(4):199-210
Radiofrequency trigeminal rhizolysis for the treatment of trigeminal neuralgia secondary to brainstem infarction. Report of two cases
Neurosurg Focus. 1997 Jan 15;2(1)
Working with a chronic disorder--the development of the Work and Handicap Questionnaire
Int J Rehabil Res. 2004 Mar;27(1):37-44
Functional magnetic resonance imaging of working memory among multiple sclerosis patients
J Neuroimaging. 2004 Apr;14(2):150-7
A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP
Clin Immunol. 2004 Apr;111(1):47-52
The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis
Ann N Y Acad Sci. 2004 Mar;1012:252-66
Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains
J Neuroimmunol. 2004 May;150(1-2):59-69
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice
Eur J Immunol. 2004 May;34(5):1251-61
Multiple sclerosis and depression
Rev Neurol. 2004 Mar 16-31;38(6):524-9
Pediatric multiple sclerosis
Curr Neurol Neurosci Rep. 2004 May;4(3):245-52
The relationship of sleep disturbances and fatigue in multiple sclerosis
Arch Neurol. 2004 Apr;61(4):525-8
Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis
J Comp Neurol. 2004 May 17;473(1):128-36
The effect of cannabis on tremor in patients with multiple sclerosis
Neurology. 2004 Apr 13;62(7):1105-9
Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG
J Neurol. 2004 Apr;251(4):414-20
Leptin enhances the release of cytokines by peripheral blood mononuclear cells from relapsing multiple sclerosis patients
J Clin Immunol. 2004 May;24(3):287-93
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis
J Immunol. 2004 Apr 15;172(8):5120-7
Platelet-activating factor acetylhydrolase gene polymorphism and its activity in Japanese patients with multiple sclerosis
J Neuroimmunol. 2004 May;150(1-2):150-6
Diffusion tensor imaging of the brain: review of clinical applications
Neuroradiology. 2004 May;46(5):339-50. Epub 2004 Apr 21
Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6698-703. Epub 2004 Apr 19
Search for morbillivirus proteins in multiple sclerosis brain tissue
Neuroreport. 2004 Jan 19;15(1):27-32
Interleukin-10 polymorphisms in Spanish type 1 diabetes patients
Genes Immun. 2004 Apr 1
Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells
J Neuroimmunol. 2004 May;150(1-2):163-77
An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: a report from the Canadian Collaborative Study Group
Hum Mol Genet. 2004 May 15;13(10):1005-1015. Epub 2004 Apr 06
Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress
Ann N Y Acad Sci. 2004 Mar;1012:84-93
Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease
J Immunol. 2004 May 1;172(9):5790-8
T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis
Clin Immunol. 2004 Apr;111(1):53-60
Mitoxantrone: a review of its use in multiple sclerosis
CNS Drugs. 2004;18(6):379-96
Glatiramer: new preparation. No place in multiple sclerosis
Prescrire Int. 2004 Feb;13(69):10-2
Statins as potential therapeutic agents in multiple sclerosis
Curr Neurol Neurosci Rep. 2004 May;4(3):237-44
Role of protein kinase R in double-stranded RNA-induced expression of nitric oxide synthase in human astroglia
FEBS Lett. 2004 Apr 9;563(1-3):223-8
Redox metals in Alzheimer's disease
Ann N Y Acad Sci. 2004 Mar;1012:171-8
Humanized animal models for autoimmune diseases
Tissue Antigens. 2004 May;63(5):383-94
Non-invasive measurement of brain damage in a primate model of multiple sclerosis
Trends Mol Med. 2004 Feb;10(2):85-91
Interferon-beta(1b) leads to a short-term increase of soluble but long-term stabilisation of cell surface bound adhesion molecules in multiple sclerosis
J Neurol. 2004 Apr;251(4):464-72
Seizure as the manifestation of relapse of multiple sclerosis in a military pilot
Aviat Space Environ Med. 2004 Apr;75(4):367-9
Bilateral spontaneous periacetabular fracture: an unusual complication of multiple sclerosis
J Orthop Trauma. 2004 Mar;18(3):182-5
Case Study of Woman with Multiple Sclerosis
Wiad Lek. 2003;56(11-12):591-3
Multiple sclerosis
J Clin Invest. 2004 Mar;113(6):788-94
Demyelination during anti-tumor necrosis factor alpha therapy with infliximab for Crohn's disease
Inflamm Bowel Dis. 2004 Jan;10(1):28-31
Meeting Report: 10 Years of Progress: Report from Selected Presentations at the 19th ECTRIMS Congress, 1720 September 2003, Milan, Italy
Int MS J. 2003 Dec;10(4):121
Association of APOE polymorphisms with disease severity in MS is limited to women
Neurology. 2004 Mar 9;62(5):811-4
High-dose immunosuppression and autologous hematopoietic stem cell rescue for severe multiple sclerosis
J Hematother Stem Cell Res. 2003 Dec;12(6):701-11
Acute aphasia in multiple sclerosis: A multicenter study of 22 patients
Neurology. 2004 Mar 23;62(6):974-7
Assessing fatigue in multiple sclerosis: Dutch modified fatigue impact scale
Acta Neurol Belg. 2003 Dec;103(4):185-91
Complete Protection from Relapsing Experimental Autoimmune Encephalomyelitis Induced by Syngeneic B Cells Expressing the Autoantigen
Blood. 2004 Feb 26
Astrocytic beta2-adrenergic receptors and multiple sclerosis
Neurobiol Dis. 2004 Mar;15(2):331-9
Autoimmune diseases in a Nigerian woman--a case report
West Afr J Med. 2003 Dec;22(4):361-3
Bax-ablation attenuates experimental autoimmune encephalomyelitis in mice
Neurosci Lett. 2004 Apr 15;359(3):139-42
Aggressive multiple sclerosis. Definition and specific therapeutic indication
Presse Med. 2004 Feb 14;33(3):187-91; discussion 192
Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts
Brain. 2004 May;127(Pt 5):1009-18. Epub 2004 Mar 26
Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association
Int Immunol. 2004 Apr;16(4):559-65
Peptidic complex mixtures as therapeutic agents in CNS autoimmunity
Mol Immunol. 2004 Feb;40(14-15):1075-87
Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers
J Immunol. 2004 Mar 1;172(5):2878-84
Do general and multiple sclerosis-specific quality of life instruments differ?
Can J Neurol Sci. 2004 Feb;31(1):64-71
Treatment of refractory autoimmune diseases with ablative immunotherapy
Autoimmun Rev. 2004 Feb;3(2):21-9
B-cell immunity in MS
Int MS J. 2003 Dec;10(4):110-20
Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4
Ann Neurol. 2004 Apr;55(4):563-9
Multiple sclerosis and vitamin D: an update
Eur J Clin Nutr. 2004 Mar 31
Differential cerebellar activation on functional magnetic resonance imaging during working memory performance in persons with multiple sclerosis
Arch Phys Med Rehabil. 2004 Apr;85(4):635-9
Multiple sclerosis: Brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2428-33
Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions
Neuroradiology. 2004 Feb 19
CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis
J Neuroimmunol. 2004 Apr;149(1-2):182-6
CYFIP2 is highly abundant in CD4+ cells from multiple sclerosis patients and is involved in T cell adhesion
Eur J Immunol. 2004 Apr;34(4):1217-27
The beta- and gamma-CH(2) of B27-WT's Leu(11) and Ile(18) Side Chains Play a Direct Role in Calpain Inhibition
Biochemistry. 2004 Mar 9;43(9):2596-604
Acute heart failure in a patient treated by mitoxantrone for multiple slerosis
Rev Neurol (Paris). 2003 Dec;159(12):1169-72
Current data on interferon therapy of multiple sclerosis in patients at developmental age
Neurol Neurochir Pol. 2004;38(1 Suppl 1):S45-51
Demyelinating lesions in cervical spinal cord and disability in multiple sclerosis patients
Neurol Neurochir Pol. 2004 Jan-Feb;38(1):25-9
Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders
Int Immunopharmacol. 2004 Mar;4(3):349-53
Induction of glial L-CCR mRNA expression in spinal cord and brain in experimental autoimmune encephalomyelitis
Glia. 2004 Apr 1;46(1):84-94
Chemokines and chemokine receptors in autoimmune encephalomyelitis as a model for central nervous system inflammatory disease regulation
Front Biosci. 2004 May 1;9:1500-5
Coping and psychological adjustment among people with multiple sclerosis
J Psychosom Res. 2004 Mar;56(3):355-61
Brain tissue loss occurs after suppression of enhancement in patients with multiple sclerosis treated with autologous haematopoietic stem cell transplantation
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):643-4
Can multiple sclerosis be diagnosed on a first demyelinating event?
Presse Med. 2004 Feb 14;33(3):174-9; discussion 192
Chemokine inhibition--why, when, where, which and how?
Biochem Soc Trans. 2004 Apr;32(Pt 2):366-77
Clinical callosum syndrome in a case of multiple sclerosis
Eur J Neurol. 2004 Mar;11(3):209-12
Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion
J Neuroimmunol. 2004 Apr;149(1-2):40-9
Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines
Curr Opin Mol Ther. 2004 Feb;6(1):27-33
Structural brain abnormalities in multiple sclerosis patients with major depression
Neurology. 2004 Feb 24;62(4):586-90
Of mice and not men: differences between mouse and human immunology
J Immunol. 2004 Mar 1;172(5):2731-8
Disability profile of MS did not change over 10 years in a population-based prevalence cohort
Neurology. 2004 Feb 24;62(4):601-6
Disability in elderly people with multiple sclerosis: An analysis of baseline data from the Sonya Slifka Longitudinal Multiple Sclerosis Study
NeuroRehabilitation. 2004;19(1):55-67
Does optimism affect symptom report in chronic disease?; What are its consequences for self-care behaviour and physical functioning?
J Psychosom Res. 2004 Mar;56(3):341-50
Tolerance induction by molecular mimicry: prevention and suppression of experimental autoimmune encephalomyelitis with the milk protein butyrophilin
Int Immunol. 2004 Mar;16(3):489-99
Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells
J Neurovirol. 2004 Feb;10(1):52-6
Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes
Brain. 2004 Mar 3
Effect of interferon beta-1a on serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in relapsing remitting multiple sclerosis patients - One year follow-up results
J Neurol. 2004 Mar;251(3):279-83
Effects of interferon-gamma and tumor necrosis factor-alpha on survival and differentiation of oligodendrocyte progenitors
J Soc Gynecol Investig. 2004 Feb;11(2):89-96
Episodic disseminated inflammation of the central nervous system. Case mix review over a 13 year period
Rev Neurol. 2004 Mar 1-15;38(5):405-10
A role of late Epstein-Barr virus infection in multiple sclerosis
Acta Neurol Scand. 2004 Apr;109(4):270-5
Disappearing "T1 black holes" in an animal model of multiple sclerosis
Front Biosci. 2004 May 1;9:1222-7
Effects of interferon- [Formula: see text] on microglial functions as inflammatory and antigen presenting cells in the central nervous system
Neuropharmacology. 2004 Apr;46(5):734-42
Endothelial microparticles as markers of endothelial dysfunction
Front Biosci. 2004 May 1;9:1118-35
Epidemiology of fecal incontinence
Gastroenterology. 2004 Jan;126(1 Suppl 2):S3-7
Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis
J Neuroimmunol. 2004 Apr;149(1-2):84-9
Estrogen, A Double-Edged Sword: Modulation of TH1- and TH2-Mediated Inflammations by Differential Regulation of TH1/TH2 Cytokine Production
Curr Drug Targets Inflamm Allergy. 2004 Mar;3(1):97-104
Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes
J Neurosci Res. 2004 Mar 1;75(5):603-13
Effects of sudden, passive muscle shortening according to Grimaldi's method on patients suffering from multiple sclerosis: a randomized controlled trial
Neurorehabil Neural Repair. 2004 Mar;18(1):47-52
INTERMED: a measure of biopsychosocial case complexity: one year stability in Multiple Sclerosis patients
Gen Hosp Psychiatry. 2004 Mar-Apr;26(2):147-52
MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort
Neurology. 2004 Mar 9;62(5):806-8
Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis
Neuroimage. 2004 Apr;21(4):1825-9
Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis
Neuropathol Appl Neurobiol. 2004 Apr;30(2):106-17
Single-step purification and refolding of recombinant mouse and human myelin oligodendrocyte glycoprotein and induction of EAE in mice
Protein Expr Purif. 2004 Apr;34(2):249-56
Fatigue in neurological disorders
Lancet. 2004 Mar 20;363(9413):978-88
Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica
J Neurol. 2004 Jan;251(1):47-52
Focus groups: the lived experience of participants with multiple sclerosis
J Neurosci Nurs. 2004 Feb;36(1):42-7
Gene therapy in a murine model for clinical application to multiple sclerosis
Ann Neurol. 2004 Mar;55(3):390-9
The influence of geographical background on the clinical and neurophysiological characteristics of patients with multiple sclerosis in Cuba
Rev Neurol. 2004 Feb 16-29;38(4):311-5
BCcogSEP: a French test battery evaluating cognitive functions in multiple sclerosis
Rev Neurol (Paris). 2004 Jan;160(1):51-62
Inducible expression of FGF2 by a rat oligodendrocyte precursor cell line promotes CNS myelination in vitro.
Exp Neurol. 2003 Dec;184(2):912-22
Fas ligand-mediated apoptosis in degenerative disorders of the brain
J Clin Immunol. 2003 Nov;23(6):439-46
Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis
J Neurosci Res. 2004 Mar 1;75(5):597-602
Extended haplotype analysis in the HLA complex reveals an increased frequency of the HFE-C282Y mutation in individuals with multiple sclerosis
Hum Genet. 2004 Mar 11

Source details

Archive capture: 2017-06-13. This is not a medical review date.

View archived source